WallStSmart
DSGN

Design Therapeutics Inc

NASDAQ: DSGN · HEALTHCARE · BIOTECHNOLOGY

$13.41
+1.82% today

Updated 2026-05-05

Market cap
$822.56M
P/E ratio
P/S ratio
29,402.82x
EPS (TTM)
$-1.19
Dividend yield
52W range
$3 – $17
Volume
0.4M

Design Therapeutics Inc (DSGN) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
6 of 8
Last 8 quarters
Avg EPS surprise
+0.9%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
-12.5%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
+1.9%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
+10.1%
2025-11-05
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-17$-0.27+18.2%$10.99$10.30-6.3%
2025-11-05$-0.30+10.9%$6.24$6.87+10.1%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.33$-0.27+18.2%
2025-09-30$-0.34$-0.30+10.9%
2025-06-30$-0.30$-0.34-14.6%
2025-03-31$-0.28$-0.31-10.7%
2024-12-31$-0.27$-0.24+10.0%$588000.00-29.8%
2024-09-30$-0.24$-0.23+4.2%
2024-06-30$-0.23$-0.21+8.7%
2024-03-31$-0.26$-0.20+23.1%
2023-12-31$-0.31$-0.21+32.3%$838000.00
2023-09-30$-0.41$-0.28+31.7%
2023-06-30$-0.40$-0.36+10.0%
2023-03-31$-0.36$-0.35+2.8%

Frequently asked questions

Has Design Therapeutics Inc beaten earnings estimates?
Design Therapeutics Inc has beaten Wall Street EPS estimates in 6 of its last 8 quarterly reports, with an average EPS surprise of +0.9% over the last 4 quarters.
How does DSGN stock react to earnings?
DSGN stock has moved an average of +1.9% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.